<DOC>
	<DOCNO>NCT02772848</DOCNO>
	<brief_summary>The study objectives describe : 1 . Obtain serum specimen collect one ovulatory cycle maximum 33 day , exceed total 550 ml whole blood per subject minimum 60 healthy , premenopausal subject . Specimens use determine reference range estradiol , FSH , LH , progesterone assay , use aid assessment fertility adult , premenopausal woman . 2 . To store remain specimen use future assay development evaluate yet undetermined assay development IVDs , include additional estradiol , FSH , LH , progesterone assay .</brief_summary>
	<brief_title>Fertility Healthy Premenopausal Women</brief_title>
	<detailed_description>The purpose study obtain sufficient specimen correlate clinical data well-controlled prospective clinical trial collect specimen healthy , premenopausal subject support domestic international regulatory submission fertility biomarker assay , establish collection specimen support future assay discovery validation effort .</detailed_description>
	<criteria>Females , age ≥ 21 year Premenopausal ( define woman least one menstrual cycle last 365 day ) . A minimum weight 110 lbs The subject anemic ( Hemoglobin ≥ 12.5 g/dL ) Willing provide daily blood draw one ovulatory cycle maximum 33 day Able understand willing provide inform consent . Males Females , age &lt; 21 year Weighing &lt; 110 lbs Anemic ( Hemoglobin &lt; 12.5 g/dL ) History bilateral oophorectomy Females take form hormonal birth control include : Oral contraceptive pill ( combine progestinonly ) within five day enrollment . Contraceptive patch ( Ortho Evra® ) within seven day enrollment . Vaginal contraceptive ring ( NuvaRing™ ) within 21 day enrollment . Contraceptive injection ( DepoProvera® ) within 90 day enrollment . Intrauterine system ( IUS ) within 90 day enrollment . An intrauterine device ( IUD ) make copper exclude patient participate study . Subdermal contraceptive implant ( Nexplanon® ) within 90 day enrollment . Emergency contraceptive within 30 day enrollment . Women menopause ( defined end menstrual cycle least 365 day since last menstrual cycle ) Amenorrhea except woman continue ovulate document physician note available enrol center . Has current diagnosis clinically significant cardiac , respiratory , neurological , immunological , hematological , liver disease , renal disease , gastrointestinal ( GI ) disorder , include history hyper hypothyroid , peptic gastric ulcer GI bleeding , condition , opinion investigator , would deem subject unhealthy therefore , ineligible . Has history clinically significant cardiac , respiratory , neurological , immunological , hematological , liver disease , renal disease , gastrointestinal ( GI ) disorder , include history hyper hypothyroid , peptic gastric ulcer GI bleeding , condition , opinion investigator , unstable time enrollment . Is receive systemic chemotherapy radiation treatment , active malignancy type , diagnose cancer within 5 year screen basal squamous cell skin cancer insitu cervical cancer . History seizure Diagnosed infectious disease include sexually transmit disease . Diagnosed HIV/AIDS ever test positive HIV . History hepatitis Subject sexual contact person hepatitis within last 12 month . Pregnancy , lactation actively seek conceive ( try become pregnant ) . Unable provide inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>